Dydrogesterone - Lgm Pharma, Isopregnenone


Buy Dydrogesterone - Lgm Pharma, IsopregnenoneCheap Dydrogesterone - Lgm Pharma, IsopregnenoneOrder Dydrogesterone - Lgm Pharma, IsopregnenoneDydrogesterone - Lgm Pharma, Isopregnenone Online No PrescriptionDydrogesterone - Lgm Pharma, Isopregnenone Online NowDydrogesterone - Lgm Pharma, Isopregnenone Without Prescriptions
Customer reviews
KPACHODAP
nice question
HotLadY-3
Topic is not fully disclosed, but the idea is interesting. I went to google.
Dl
Such gloomy pictures :)
estochka
I apologize, but, in my opinion, you are not right. Let's discuss it. Write to me in PM, we will talk.
krokk
It’s all about ultimate masculine attractiveness and sexual performance! Learn more now!
murzik
Yes, indeed. I join all of the above the above. We can talk about it.
PhotoByKholinaAnna
A man should always stay a man! That’s why you have to take care of your health!
Zoika
cool!!
Geras1m
Good post! Podcherpnul a lot of new and interesting!
Lusielle
It can not be

Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.

Dydrogesterone is an orally active progestogen which acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus. At therapeutic levels, dydrogesterone has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum. Furthermore, dydrogesterone is non-androgenic, non-estrogenic, non-corticoid, non-anabolic and is not excreted as pregnanediol. Dydrogesterone helps to regulate the healthy growth and normal shedding of the uterus lining. Therefore, it may be useful in the treatment of menstrual disorders such as absent, irregular or painful menstrual periods, infertility, premenstrual syndrome and endometriosis.

Dydrogesterone is a progestogen that works by regulating the healthy growth and normal shedding of the womb lining by acting on progesterone receptors in the uterus.

Metabolism is complete to a 20-dihydrodydrogesterone (DHD) metabolite.

No serious or unexpected toxicity has been observed with dydrogesterone. In acute toxicity studies, the LD50 doses in rats exceeded 4,640mg/kg for the oral route.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

Cost effective materials based on specific requirements

Small quantities for initial research and larger development quantities towards product commercialization

Technical packages, letters of access to filed DMFs

Complete assistance in any regulatory filings

Top quality GMP certified manufacturers

Have necessary regulatory credentials

Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.

Dydrogesterone is an orally active progestogen which acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus. At therapeutic levels, dydrogesterone has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum. Furthermore, dydrogesterone is non-androgenic, non-estrogenic, non-corticoid, non-anabolic and is not excreted as pregnanediol. Dydrogesterone helps to regulate the healthy growth and normal shedding of the uterus lining. Therefore, it may be useful in the treatment of menstrual disorders such as absent, irregular or painful menstrual periods, infertility, premenstrual syndrome and endometriosis.

Dydrogesterone is a progestogen that works by regulating the healthy growth and normal shedding of the womb lining by acting on progesterone receptors in the uterus.

Metabolism is complete to a 20-dihydrodydrogesterone (DHD) metabolite.

No serious or unexpected toxicity has been observed with dydrogesterone. In acute toxicity studies, the LD50 doses in rats exceeded 4,640mg/kg for the oral route.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

Cost effective materials based on specific requirements

Small quantities for initial research and larger development quantities towards product commercialization

Technical packages, letters of access to filed DMFs

Complete assistance in any regulatory filings

Top quality GMP certified manufacturers

Have necessary regulatory credentials